• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体与核疾病检测组合(Mito-aND-Panel):采用一种经济高效且灵敏的基于二代测序(NGS)的方法对线粒体DNA和核DNA进行联合测序。

Mitochondrial and nuclear disease panel (Mito-aND-Panel): Combined sequencing of mitochondrial and nuclear DNA by a cost-effective and sensitive NGS-based method.

作者信息

Abicht Angela, Scharf Florentine, Kleinle Stephanie, Schön Ulrike, Holinski-Feder Elke, Horvath Rita, Benet-Pagès Anna, Diebold Isabel

机构信息

Medical Genetic Center Munich, Munich, Germany.

Department of Neurology, Friedrich-Baur-Institute, Klinikum der Ludwig-Maximilians-Universität München, Munich, Germany.

出版信息

Mol Genet Genomic Med. 2018 Nov;6(6):1188-1198. doi: 10.1002/mgg3.500. Epub 2018 Nov 8.

DOI:10.1002/mgg3.500
PMID:30406974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6305657/
Abstract

BACKGROUND

The diagnosis of mitochondrial disorders is challenging because of the clinical variability and genetic heterogeneity of these conditions. Next-Generation Sequencing (NGS) technology offers a robust high-throughput platform for nuclear and mitochondrial DNA (mtDNA) analyses.

METHOD

We developed a custom Agilent SureSelect Mitochondrial and Nuclear Disease Panel (Mito-aND-Panel) capture kit that allows parallel enrichment for subsequent NGS-based sequence analysis of nuclear mitochondrial disease-related genes and the complete mtDNA genome. Sequencing of enriched mtDNA simultaneously with nuclear genes was compared with the separated sequencing of the mitochondrial genome and whole exome sequencing (WES).

RESULTS

The Mito-aND-Panel permits accurate detection of low-level mtDNA heteroplasmy due to a very high sequencing depth compared to standard diagnostic procedures using Sanger sequencing/SNaPshot and WES which is crucial to identify maternally inherited mitochondrial disorders.

CONCLUSION

We established a NGS-based method with combined sequencing of the complete mtDNA and nuclear genes which enables a more sensitive heteroplasmy detection of mtDNA mutations compared to traditional methods. Because the method promotes the analysis of mtDNA variants in large cohorts, it is cost-effective and simple to setup, we anticipate this is a highly relevant method for sequence-based genetic diagnosis in clinical diagnostic applications.

摘要

背景

线粒体疾病的诊断具有挑战性,因为这些病症存在临床变异性和遗传异质性。下一代测序(NGS)技术为核DNA和线粒体DNA(mtDNA)分析提供了一个强大的高通量平台。

方法

我们开发了一种定制的安捷伦SureSelect线粒体和核疾病检测试剂盒(Mito-aND-Panel)捕获试剂盒,该试剂盒允许对核线粒体疾病相关基因和完整的mtDNA基因组进行平行富集,以便后续基于NGS的序列分析。将富集的mtDNA与核基因同时测序与线粒体基因组单独测序和全外显子组测序(WES)进行比较。

结果

与使用桑格测序/SNaPshot和WES的标准诊断程序相比,Mito-aND-Panel由于测序深度非常高,能够准确检测低水平的mtDNA异质性,这对于识别母系遗传的线粒体疾病至关重要。

结论

我们建立了一种基于NGS的方法,对完整的mtDNA和核基因进行联合测序,与传统方法相比,该方法能够更灵敏地检测mtDNA突变。由于该方法促进了对大量队列中mtDNA变异的分析,具有成本效益且设置简单,我们预计这是一种在临床诊断应用中基于序列的基因诊断的高度相关方法。

相似文献

1
Mitochondrial and nuclear disease panel (Mito-aND-Panel): Combined sequencing of mitochondrial and nuclear DNA by a cost-effective and sensitive NGS-based method.线粒体与核疾病检测组合(Mito-aND-Panel):采用一种经济高效且灵敏的基于二代测序(NGS)的方法对线粒体DNA和核DNA进行联合测序。
Mol Genet Genomic Med. 2018 Nov;6(6):1188-1198. doi: 10.1002/mgg3.500. Epub 2018 Nov 8.
2
Mitochondrial disease genetic diagnostics: optimized whole-exome analysis for all MitoCarta nuclear genes and the mitochondrial genome.线粒体疾病基因诊断:对所有线粒体编码基因(MitoCarta)的核基因和线粒体基因组进行优化的全外显子组分析。
Discov Med. 2012 Dec;14(79):389-99.
3
Combined MITOchondrial-NUCLEAR (MITO-NUCLEAR) Analysis for Mitochondrial Diseases Diagnosis: Validation and Implementation of a One-Step NGS Method.联合线粒体-核(MITO-NUCLEAR)分析在诊断线粒体疾病中的应用:一步式 NGS 方法的验证与实施。
Genes (Basel). 2023 May 15;14(5):1087. doi: 10.3390/genes14051087.
4
Comprehensive Mitochondrial Genome Analysis by Massively Parallel Sequencing.通过大规模平行测序进行线粒体基因组综合分析
Methods Mol Biol. 2016;1351:3-17. doi: 10.1007/978-1-4939-3040-1_1.
5
Mitochondrial DNA enrichment reduced NUMT contamination in porcine NGS analyses.线粒体DNA富集减少了猪二代测序分析中的核线粒体DNA污染。
Brief Bioinform. 2020 Jul 15;21(4):1368-1377. doi: 10.1093/bib/bbz060.
6
Novel economical, accurate, sensitive, single-cell analytical method for mitochondrial DNA quantification in mtDNA mutation carriers.用于 mtDNA 突变携带者中线粒体 DNA 定量的新型经济、准确、敏感的单细胞分析方法。
J Assist Reprod Genet. 2023 Sep;40(9):2197-2209. doi: 10.1007/s10815-023-02878-w. Epub 2023 Jul 18.
7
MitoRS, a method for high throughput, sensitive, and accurate detection of mitochondrial DNA heteroplasmy.线粒体DNA异质性高通量、灵敏且准确检测方法(MitoRS)。
BMC Genomics. 2017 Apr 26;18(1):326. doi: 10.1186/s12864-017-3695-5.
8
Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.在靶向基因panel分析中,临床下一代测序流程优于使用桑格测序和多重连接依赖探针扩增的联合方法。
J Mol Diagn. 2016 Sep;18(5):657-667. doi: 10.1016/j.jmoldx.2016.04.002. Epub 2016 Jul 2.
9
MITO-FIND: A study in 390 patients to determine a diagnostic strategy for mitochondrial disease.MITO-FIND:一项针对 390 名患者的研究,旨在确定线粒体疾病的诊断策略。
Mol Genet Metab. 2020 Sep-Oct;131(1-2):66-82. doi: 10.1016/j.ymgme.2020.08.009. Epub 2020 Sep 18.
10
Improving post-natal detection of mitochondrial DNA mutations.提高产后线粒体 DNA 突变的检测率。
Expert Rev Mol Diagn. 2020 Oct;20(10):1003-1008. doi: 10.1080/14737159.2020.1820326. Epub 2020 Sep 20.

引用本文的文献

1
Experiences from dual genome next-generation sequencing panel testing for mitochondrial disorders: a comprehensive molecular diagnosis.线粒体疾病的双基因组下一代测序面板检测经验:全面的分子诊断
Front Genet. 2025 Mar 5;16:1488956. doi: 10.3389/fgene.2025.1488956. eCollection 2025.
2
Variability of Clinical Phenotypes Caused by Isolated Defects of Mitochondrial ATP Synthase.孤立性线粒体 ATP 合酶缺陷导致的临床表型变异性。
Physiol Res. 2024 Aug 31;73(Suppl 1):S243-S278. doi: 10.33549/physiolres.935407. Epub 2024 Jul 17.
3
Quality assurance within the context of genome diagnostics (a german perspective).

本文引用的文献

1
Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.基于新一代测序的肿瘤学检测板验证指南:分子病理学协会和美国病理学家学会联合共识推荐
J Mol Diagn. 2017 May;19(3):341-365. doi: 10.1016/j.jmoldx.2017.01.011. Epub 2017 Mar 21.
2
Expanding Our Understanding of mtDNA Deletions.扩展我们对 mtDNA 缺失的理解。
Cell Metab. 2016 Jul 12;24(1):3-4. doi: 10.1016/j.cmet.2016.06.024.
3
mtDNA-Server: next-generation sequencing data analysis of human mitochondrial DNA in the cloud.
基因组诊断背景下的质量保证(德国视角)
Med Genet. 2023 Jun 13;35(2):91-104. doi: 10.1515/medgen-2023-2028. eCollection 2023 Jun.
4
[Migraine and mitochondrial diseases : Energy deficit in the brain].[偏头痛与线粒体疾病:大脑中的能量缺乏]
Nervenarzt. 2024 Feb;95(2):169-178. doi: 10.1007/s00115-024-01622-8.
5
[Migraine and mitochondrial diseases : Energy deficit in the brain].[偏头痛与线粒体疾病:大脑中的能量不足]
Schmerz. 2023 Dec;37(6):473-482. doi: 10.1007/s00482-023-00764-z. Epub 2023 Nov 3.
6
Novel economical, accurate, sensitive, single-cell analytical method for mitochondrial DNA quantification in mtDNA mutation carriers.用于 mtDNA 突变携带者中线粒体 DNA 定量的新型经济、准确、敏感的单细胞分析方法。
J Assist Reprod Genet. 2023 Sep;40(9):2197-2209. doi: 10.1007/s10815-023-02878-w. Epub 2023 Jul 18.
7
Combined MITOchondrial-NUCLEAR (MITO-NUCLEAR) Analysis for Mitochondrial Diseases Diagnosis: Validation and Implementation of a One-Step NGS Method.联合线粒体-核(MITO-NUCLEAR)分析在诊断线粒体疾病中的应用:一步式 NGS 方法的验证与实施。
Genes (Basel). 2023 May 15;14(5):1087. doi: 10.3390/genes14051087.
8
Whole exome sequencing is an alternative method in the diagnosis of mitochondrial DNA diseases.全外显子组测序是诊断线粒体 DNA 疾病的一种替代方法。
Mol Genet Genomic Med. 2022 Jun;10(6):e1943. doi: 10.1002/mgg3.1943. Epub 2022 Apr 7.
9
A benchmarking of human mitochondrial DNA haplogroup classifiers from whole-genome and whole-exome sequence data.全基因组和全外显子组序列数据中人线粒体 DNA 单倍群分类器的基准测试。
Sci Rep. 2021 Oct 15;11(1):20510. doi: 10.1038/s41598-021-99895-5.
10
Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).临床实验室染色体结构变异的新一代测序检测:2021 年修订版:美国医学遗传学与基因组学学会(ACMG)的技术标准。
Genet Med. 2021 Aug;23(8):1399-1415. doi: 10.1038/s41436-021-01139-4. Epub 2021 Apr 29.
线粒体DNA服务器:云端人类线粒体DNA的下一代测序数据分析
Nucleic Acids Res. 2016 Jul 8;44(W1):W64-9. doi: 10.1093/nar/gkw247. Epub 2016 Apr 15.
4
New genes and pathomechanisms in mitochondrial disorders unraveled by NGS technologies.通过NGS技术揭示的线粒体疾病中的新基因和发病机制
Biochim Biophys Acta. 2016 Aug;1857(8):1326-1335. doi: 10.1016/j.bbabio.2016.02.022. Epub 2016 Mar 8.
5
Guidelines for diagnostic next-generation sequencing.诊断性下一代测序指南。
Eur J Hum Genet. 2016 Jan;24(1):2-5. doi: 10.1038/ejhg.2015.226. Epub 2015 Oct 28.
6
PCR-Free Enrichment of Mitochondrial DNA from Human Blood and Cell Lines for High Quality Next-Generation DNA Sequencing.用于高质量下一代DNA测序的人血和细胞系线粒体DNA的无PCR富集
PLoS One. 2015 Oct 21;10(10):e0139253. doi: 10.1371/journal.pone.0139253. eCollection 2015.
7
MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins.线粒体蛋白质组数据库2.0:哺乳动物线粒体蛋白的更新清单。
Nucleic Acids Res. 2016 Jan 4;44(D1):D1251-7. doi: 10.1093/nar/gkv1003. Epub 2015 Oct 7.
8
Mitochondrial Disease Sequence Data Resource (MSeqDR): a global grass-roots consortium to facilitate deposition, curation, annotation, and integrated analysis of genomic data for the mitochondrial disease clinical and research communities.线粒体疾病序列数据资源(MSeqDR):一个全球基层联盟,旨在促进为线粒体疾病临床和研究群体进行基因组数据的提交、管理、注释及综合分析。
Mol Genet Metab. 2015 Mar;114(3):388-96. doi: 10.1016/j.ymgme.2014.11.016. Epub 2014 Dec 4.
9
Next-generation sequencing of the mitochondrial genome and association with IgA nephropathy in a renal transplant population.肾移植人群中线粒体基因组的下一代测序及其与IgA肾病的关联
Sci Rep. 2014 Dec 9;4:7379. doi: 10.1038/srep07379.
10
The genomic landscape of polymorphic human nuclear mitochondrial insertions.多态性人类核线粒体插入的基因组格局
Nucleic Acids Res. 2014 Nov 10;42(20):12640-9. doi: 10.1093/nar/gku1038. Epub 2014 Oct 27.